View in EDS HTML Full Text PDF Full Text

Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial.

Saved in:
Bibliographic Details
Title: Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial.
Authors: Lee DK; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Lee CK; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea., Kim HS; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea., Sym SJ; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea., Zang DY; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Korea., Kim KH; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea., Lim JH; Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea., Kim HS; Division of Hematology-Oncology, Department of Medicine, Veterans Health Service Medical Center, Seoul, Korea., Lee KH; Division of Hematology and Oncology, Department of Internal Medicine, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu, Korea., Gee HY; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea., Rha SY; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea., Kim H; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea., Jung M; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.
Source: Cancer research and treatment [Cancer Res Treat] 2025 Jul; Vol. 57 (3), pp. 770-780. Date of Electronic Publication: 2024 Nov 12.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39529388
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+DK%22">Lee DK</searchLink>; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+CK%22">Lee CK</searchLink>; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HS%22">Kim HS</searchLink>; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Sym+SJ%22">Sym SJ</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.<br /><searchLink fieldCode="AU" term="%22Zang+DY%22">Zang DY</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+KH%22">Kim KH</searchLink>; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.<br /><searchLink fieldCode="AU" term="%22Lim+JH%22">Lim JH</searchLink>; Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HS%22">Kim HS</searchLink>; Division of Hematology-Oncology, Department of Medicine, Veterans Health Service Medical Center, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+KH%22">Lee KH</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu, Korea.<br /><searchLink fieldCode="AU" term="%22Gee+HY%22">Gee HY</searchLink>; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Rha+SY%22">Rha SY</searchLink>; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+H%22">Kim H</searchLink>; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Jung+M%22">Jung M</searchLink>; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101155137%22">Cancer research and treatment</searchLink> [Cancer Res Treat] 2025 Jul; Vol. 57 (3), pp. 770-780. <i>Date of Electronic Publication: </i>2024 Nov 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Korean+Cancer+Association%22">Korean Cancer Association </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>101155137 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2005-9256 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215982998%22">15982998 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39529388
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.4143/crt.2024.705
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 770
    Titles:
      – TitleFull: Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee DK
      – PersonEntity:
          Name:
            NameFull: Lee CK
      – PersonEntity:
          Name:
            NameFull: Kim HS
      – PersonEntity:
          Name:
            NameFull: Sym SJ
      – PersonEntity:
          Name:
            NameFull: Zang DY
      – PersonEntity:
          Name:
            NameFull: Kim KH
      – PersonEntity:
          Name:
            NameFull: Lim JH
      – PersonEntity:
          Name:
            NameFull: Kim HS
      – PersonEntity:
          Name:
            NameFull: Lee KH
      – PersonEntity:
          Name:
            NameFull: Gee HY
      – PersonEntity:
          Name:
            NameFull: Rha SY
      – PersonEntity:
          Name:
            NameFull: Kim H
      – PersonEntity:
          Name:
            NameFull: Jung M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2005-9256
          Numbering:
            – Type: volume
              Value: 57
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Cancer research and treatment
              Type: main
ResultId 1